Schilling AF - Search Results

1

Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2.

Schulze J, Seitz S, Saito H, Schneebauer M, Marshall RP, Baranowsky A, Busse B, Schilling AF, Friedrich FW, Albers J, Spiro AS, Zustin J, Streichert T, Ellwanger K, Niehrs C, Amling M, Baron R, Schinke T. Schulze J, et al. Among authors: schilling af. PLoS One. 2010 Apr 27;5(4):e10309. doi: 10.1371/journal.pone.0010309. PLoS One. 2010. PMID: 20436912 Free PMC article.

2

Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass.

Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. Ducy P, et al. Among authors: schilling af. Cell. 2000 Jan 21;100(2):197-207. doi: 10.1016/s0092-8674(00)81558-5. Cell. 2000. PMID: 10660043 Free article.

3

Progressive increase in bone mass and development of odontomas in aging osteopetrotic c-src-deficient mice.

Amling M, Neff L, Priemel M, Schilling AF, Rueger JM, Baron R. Amling M, et al. Among authors: schilling af. Bone. 2000 Nov;27(5):603-10. doi: 10.1016/s8756-3282(00)00373-2. Bone. 2000. PMID: 11062345 Free article.

4

Biologically and chemically optimized composites of carbonated apatite and polyglycolide as bone substitution materials.

Linhart W, Peters F, Lehmann W, Schwarz K, Schilling AF, Amling M, Rueger JM, Epple M. Linhart W, et al. Among authors: schilling af. J Biomed Mater Res. 2001 Feb;54(2):162-71. doi: 10.1002/1097-4636(200102)54:2<162::aid-jbm2>3.0.co;2-3. J Biomed Mater Res. 2001. PMID: 11093175

5

[Leptin: factor in the central nervous system regulation of bone mass. Development of a new understanding of bone remodeling, skeletal reconstruction, skeletal preservation and skeletal repair].

Amling M, Schilling AF, Haberland M, Rueger JM. Amling M, et al. Among authors: schilling af. Orthopade. 2001 Jul;30(7):418-24. doi: 10.1007/s001320170072. Orthopade. 2001. PMID: 11515179 German.

6

Brain and bone: central regulation of bone mass. A new paradigm in skeletal biology.

Haberland M, Schilling AF, Rueger JM, Amling M. Haberland M, et al. Among authors: schilling af. J Bone Joint Surg Am. 2001 Dec;83(12):1871-6. doi: 10.2106/00004623-200112000-00016. J Bone Joint Surg Am. 2001. PMID: 11741068 Review. No abstract available.

7

Resorbability of bone substitute biomaterials by human osteoclasts.

Schilling AF, Linhart W, Filke S, Gebauer M, Schinke T, Rueger JM, Amling M. Schilling AF, et al. Biomaterials. 2004 Aug;25(18):3963-72. doi: 10.1016/j.biomaterials.2003.10.079. Biomaterials. 2004. PMID: 15046886

8

The Fos-related antigen Fra-1 is an activator of bone matrix formation.

Eferl R, Hoebertz A, Schilling AF, Rath M, Karreth F, Kenner L, Amling M, Wagner EF. Eferl R, et al. Among authors: schilling af. EMBO J. 2004 Jul 21;23(14):2789-99. doi: 10.1038/sj.emboj.7600282. Epub 2004 Jul 1. EMBO J. 2004. PMID: 15229648 Free PMC article.

9

Decreased bone formation and osteopenia in mice lacking alpha-calcitonin gene-related peptide.

Schinke T, Liese S, Priemel M, Haberland M, Schilling AF, Catala-Lehnen P, Blicharski D, Rueger JM, Gagel RF, Emeson RB, Amling M. Schinke T, et al. Among authors: schilling af. J Bone Miner Res. 2004 Dec;19(12):2049-56. doi: 10.1359/JBMR.040915. Epub 2004 Sep 20. J Bone Miner Res. 2004. PMID: 15537449 Free article.

10

Absence of mouse pleiotrophin does not affect bone formation in vivo.

Lehmann W, Schinke T, Schilling AF, Catalá-Lehnen P, Gebauer M, Pogoda P, Gerstenfeld LC, Rueger JM, Einhorn TA, Amling M. Lehmann W, et al. Among authors: schilling af. Bone. 2004 Dec;35(6):1247-55. doi: 10.1016/j.bone.2004.08.017. Bone. 2004. PMID: 15589206

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters